Endometrial Carcinoma

International Team Establishes Receptor Role In Female Cancer Prognosis

Published in Cancer Weekly, December 4th, 2001

by Sonia Nichols, senior medical writer - Members of the multinational Tumor and Angiogenesis Research Group say a fully functioning angiogenic pathway is typically present in endometrial carcinoma progression.

That pathway must include cellular expression of the mitogen vascular endothelial growth factor (VEGF) as well as the presence of a key receptor, flk-1(KDR), according to Alexandra Giatromanolaki and colleagues, Democritus University of Thrace, Alexandroupolis, Greece.

Giatromanolaki and a cohort of colleagues from around the world studied more than 120 endometrial carcinoma samples before coming to this conclusion. During their analyses, the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-12-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry